Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1986 Nov;89(3):583-92.
doi: 10.1111/j.1476-5381.1986.tb11159.x.

A comparison between mechanisms of action of different nicotinic blocking agents on rat submandibular ganglia

Comparative Study

A comparison between mechanisms of action of different nicotinic blocking agents on rat submandibular ganglia

W A Large et al. Br J Pharmacol. 1986 Nov.

Abstract

The blocking properties of tubocurarine, decamethonium, hexamethonium and trimetaphan on nicotinic agonists applied by repetitive ionophoretic pulses were examined in rat submandibular ganglion cells using a two-microelectrode voltage-clamp technique at 30 degrees C. Hexamethonium, a proposed slowly dissociating, open-channel blocker at concentrations of 2-20 microM did not produce a 'use-dependent' run-down of responses, but its antagonism was clearly dependent on membrane potential. The voltage-dependent reduction of agonist response by hexamethonium was not dependent on the nature of agonist used. Similar results were obtained with acetylcholine (ACh) and carbamylcholine (CCh) ionophoresis. (+)-Tubocurarine (5 microM) and decamethonium (10 microM) produced 'use-dependent' run-down of agonist responses which became more pronounced at higher frequency and as the cell was hyperpolarized, consistent with open-channel blockade. In contrast, trimetaphan (2.5 microM), a receptor antagonist did not cause 'use-dependent' run-down of responses. Hence, the antagonism produced by hexamethonium, unlike tubocurarine and decamethonium, could not be accounted for in terms of open-channel blockade but requires an alternative mechanism, the nature of which is discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Pharmacol Chemother. 1949 Dec;4(4):381-400 - PubMed
    1. J Physiol. 1979 Oct;295:139-70 - PubMed
    1. J Physiol. 1983 Jun;339:395-417 - PubMed
    1. J Physiol. 1973 Dec;235(3):655-91 - PubMed
    1. Br J Pharmacol Chemother. 1951 Mar;6(1):155-68 - PubMed

Publication types

LinkOut - more resources